DORBAXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug DORBAXIN contains one active pharmaceutical ingredient (API):

1
UNII 125OD7737X - METHOCARBAMOL
 

Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres.

 
Read more about Methocarbamol

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-5493 Tablet Dorbaxin Tablet TAB 500 mg 1 x 10's (in Alu-PVC blister) Tablet DORBAXIN TABLET METHOCARBAMOL TABLETS USP 500 MG METHOCARBAMOL USP 500MG A4-5493 Drugs MUSCULO-SKELETAL SYSTEM Imported Products 110 Prescription Only Medicine (POM) 11/12/2023 XCEL PHARMACEUTICAL LIMITED, , JONES STREET, EBUTE METTA, LAGOS 18419240 graciousdec@yahoo.co.uk STALLION LABORATORIES PVT LTD, Plot No. C1B-305, 2,3,4,&5, G.I.D.C., Kerala Ahmedabad, Gujarat State, India., India 30/01/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M03BA03 Methocarbamol M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BA Carbamic acid esters
Discover more medicines within M03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-5493

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.